Atezolizumab-Induced Bell's Palsy in a Patient With Small Cell Lung Cancer
Immune checkpoint inhibitors are rapidly becoming popular therapeutic options for patients suffering from a number of malignancies. Atezolizumab is a programmed cell death ligand-1 inhibitor, and binding to this ligand decreases the ability of tumor cells to evade the immune system, resulting in sel...
Saved in:
Main Authors: | Asim Kichloo MD (Author), Michael Stanley Albosta MD (Author), Shakeel M. Jamal MD (Author), Michael Aljadah MD (Author), Farah Wani MD (Author), Insija Selene MD (Author), Jagmeet Singh MD (Author), Asma Taj MD (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma
by: Asim Kichloo MD, et al.
Published: (2020) -
Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma
by: Asim Kichloo MD, et al.
Published: (2020) -
Acute Recurrent Exacerbations of Mesenteric Panniculitis With Immunosuppressive Therapy: A Case Report and a Brief Review
by: Dushyant Singh Dahiya MD, et al.
Published: (2020) -
Resistant Hypertension Secondary to Severe Renal Artery Stenosis With Negative Duplex Ultrasound: A Brief Review of Different Diagnostic Modalities
by: Navya Vipparla MD, et al.
Published: (2020) -
Monoclonal Gammopathy of Renal Significance-A Rare Renal Presentation: A Review of Cases Reported
by: Asim Kichloo MD, et al.
Published: (2020)